CD News Alert

CD HEALTH ALERT: Booster Dose of Pfizer BioNTech COVID-19 mRNA Vaccine

The CDC’s Director recommended that the following groups of individuals for receipt of a single booster dose of Pfizer-BioNTech COVID-19 vaccine at least six-months after completing a primary series with the Pfizer-BioNTech COVID-19 vaccine.

  • people 65 years and older and residents in long-term care facilities (LTCF) should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
  • people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
  • people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and
  • people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.

This recommendation comes after FDA modified the Emergency Use Authorizations (EUAs) on September 22, 2021 for Pfizer-BioNTech COVID-19 vaccine to allow for administration of a booster dose of an Pfizer-BioNTech COVID-19 vaccine at least six-months after an initial 2-dose primary Pfizer-BioNTech COVID-19 vaccine series.

More...